Cataract surgery and diabetic macular edema progression
Part of Eyes & vision, Hormones & metabolism clinical trials.
This trial studies how diabetic macular edema (swelling in the center of the retina) might change after cataract surgery. It may help doctors understand if surgery is safe for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have diabetes and have non-center-involving diabetic macular edema (swelling in the retina that does not affect the central part)
- You have a mild to moderate nuclear cataract (a type of clouding in the lens of your eye)
- You do not have severe diabetic retinopathy or advanced eye damage
- You have not had a traumatic cataract (caused by injury)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called CU06-1004 for people with diabetic macular edema (swelling in the center of the retina caused by diabetes). It aims to see if the drug can improve vision and reduce swelling.
This study uses a special eye scan (OCT) to look for very early signs of eye damage in people with diabetes who have no vision problems yet. It aims to catch changes before symptoms start.
This early-phase trial tests a new implant (EC-104) that goes inside the eye to treat diabetic macular edema (DME), a condition that causes blurry vision from fluid buildup. The implant slowly releases medicine over time, and the study will see if it is safe and helpful for people with DME.
This Phase 1 trial tests MS-553 to see how it works and how safely it can be given to people with diabetic retinopathy causing central macular swelling (macular edema). You may be considered if your vision and eye scan results match, and if you can follow frequent study visits.
This trial tests a gene therapy called RGX-314 for people with diabetic macular edema that affects the center of the vision. If you have had previous treatment and still have swelling, this study may be an option.
This Phase 1 study tests the safety and early effectiveness of OCU200 eye injections in people with diabetic macular edema (DME) that affects the center of vision. It may help by reducing the eye swelling that blurs vision from diabetes.
Hear when a new Diabetic Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.